January 21, 2021 — Johnson & Johnson Innovation and Johnson & Johnson Consumer Inc. announced today that Rejuven Dermaceutical and LILLYCOVER have been selected as the awardees in the Skincare of the Future QuickFire Challenge, with Alibaba’s Tmall having participated in the selection process.
The challenge invited innovators to submit late-stage ideas aimed at improving skin health, with a specific focus on pore minimizing and anti-aging solutions.
Rejuven Dermaceutical is a China-based clinical-stage biopharmaceutical company dedicated to research and development of first-in-class drugs for aethetic medical application. Its leading drug candidate is in Phase I trial in the US, targeting excessive submental adipose tissues for removal. The company also markets and sells its REJUVEN brand of anti-wrinkle and skin rejuvenating products that are based on its proprietary Protein Loss Antagonist (PLA) technology.
LILLYCOVER, initially launched as a beauty tech startup, provides potential skin regenerating solutions based on individual skin type. The company’s skin analysis device utilizes a sensor and smartphone app with the aim to provide users with detailed skin data and customized skincare recommendations.
Rejuven Dermaceutical and LILLYCOVER will receive up to $50,000 in grant funding, one year of residency at JLABS @ Shanghai, mentorship from the Johnson & Johnson Family of Companies, and the chance to launch their product through Alibaba’s Tmall, China’s premier B2C platform for brands and retailers, with the aim to help them cultivate their product in the Chinese market.
The QuickFire Challenges are managed by Johnson & Johnson Innovation, with the goal to address today’s greatest health care challenges.